UNIVERSITY OF CALIFORNIA – SAN DIEGO IMAGE: DON CLEVELAND, PHD, DISTINGUISHED PROFESSOR OF MEDICINE, NEUROSCIENCES AND CELLULAR AND MOLECULAR MEDICINE AT UC SAN DIEGO SCHOOL OF MEDICINE, IS AMONG THE MOST HIGHLY CITED RESEARCHERS IN THE WORLD FOR HIS WORK INVESTIGATING NEURODEGENERATIVE DISEASES. CREDIT: ERIK JEPSEN, UC SAN DIEGO In virtually all persons with amyotrophic...
TOHO UNIVERSITY IMAGE: ON THE 2-MINUTE WALK TEST, AN INCREASED WALKING DISTANCE WAS OBSERVED IN 10 OUT OF 11 PATIENTS. THE MEAN WALKING DISTANCE ALSO IMPROVED AFTER HAL-BASED TRAINING. CREDIT: OSAMU KANO Amyotrophic lateral sclerosis (ALS) is a fatal progressive neurodegenerative disease that presents with various symptoms, such as muscle weakness, dysphagia, dysarthria, and respiratory...
by Suzanne Leigh, University of California, San Francisco NP001 targets macrophages, a type of immune cell implicated in the destruction of neurons. Credit: Michael S. McGrath, MD, PhD A new drug has been found to slow or temporarily stall the progression of ALS (amyotrophic lateral sclerosis) in a select group of patients. The drug, a...
